We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$85.3M
Cap. Flow
-$23.1M
Cap. Flow %
-3.19%
Top 10 Hldgs %
36.06%
Holding
97
New
24
Increased
24
Reduced
14
Closed
32

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$23M
2
DXCM icon
DexCom
DXCM
+$19.7M
3
MDT icon
Medtronic
MDT
+$18.4M
4
BDX icon
Becton Dickinson
BDX
+$17.6M
5
AMGN icon
Amgen
AMGN
+$16.2M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$34.2M
2
ZBH icon
Zimmer Biomet
ZBH
+$29.2M
3
COO icon
Cooper Companies
COO
+$13.6M
4
CNC icon
Centene
CNC
+$13.5M
5
ABBV icon
AbbVie
ABBV
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.17%
2 Consumer Discretionary 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$21B
$35.6M 4.93%
540,000
+308,000
+133% +$23M
ARGX icon
2
argenx
ARGX
$54B
$34.4M 4.76%
70,000
+30,000
+75% +$14.7M
BSX icon
3
Boston Scientific
BSX
$68.8B
$29M 4.02%
550,000
+84,000
+18% +$4.41M
MLTX icon
4
MoonLake Immunotherapeutics
MLTX
$1.49B
$28.5M 3.95%
500,000
+200,000
+67% +$11M
CYTK icon
5
Cytokinetics
CYTK
$10.6B
$23.6M 3.26%
800,000
+150,000
+23% +$5M
MDT icon
6
Medtronic
MDT
$109B
$23.5M 3.25%
300,000
+220,000
+275% +$18.4M
NARI
7
DELISTED
Inari Medical, Inc. Common Stock
NARI
$22.9M 3.17%
350,000
+195,000
+126% +$12.3M
MCK icon
8
McKesson
MCK
$98.8B
$21.7M 3.01%
50,000
-22,000
-31% -$9.27M
INSP icon
9
Inspire Medical Systems
INSP
$1.72B
$20.8M 2.88%
105,000
+2,000
+2% +$504K
NVS icon
10
Novartis
NVS
$293B
$20.4M 2.82%
200,000
+97,000
+94% +$9.85M
COR icon
11
Cencora
COR
$61.6B
$19.8M 2.74%
110,000
+84,000
+323% +$15.5M
AMGN icon
12
Amgen
AMGN
$220B
$17.5M 2.42%
+65,000
New +$16.2M
CI icon
13
Cigna
CI
$71.3B
$17.2M 2.38%
60,000
-120,000
-67% -$34.2M
BDX icon
14
Becton Dickinson
BDX
$46.5B
$16.8M 2.33%
+65,000
New +$17.6M
EHC icon
15
Encompass Health
EHC
$11B
$16.8M 2.32%
250,000
+30,000
+14% +$2.06M
DXCM icon
16
DexCom
DXCM
$31.3B
$16.3M 2.26%
+175,000
New +$19.7M
VTYX
17
DELISTED
Ventyx Biosciences
VTYX
$14.9M 2.07%
430,000
+80,000
+23% +$2.77M
RVMD icon
18
Revolution Medicines
RVMD
$41.3B
$14.5M 2.01%
525,000
+169,000
+47% +$5.01M
LLY icon
19
Eli Lilly
LLY
$1.02T
$13.4M 1.86%
25,000
-5,000
-17% -$2.58M
CRSP icon
20
CRISPR Therapeutics
CRSP
$5.19B
$12.5M 1.73%
275,000
+175,000
+175% +$9.04M
MOH icon
21
Molina Healthcare
MOH
$10B
$11.5M 1.59%
+35,000
New +$11M
TDOC icon
22
Teladoc Health
TDOC
$1.26B
$11.2M 1.54%
600,000
+400,000
+200% +$9.34M
RVTY icon
23
Revvity
RVTY
$12.7B
$11.1M 1.53%
100,000
-40,000
-29% -$4.7M
AVTR icon
24
Avantor
AVTR
$9.1B
$11.1M 1.53%
+525,000
New +$11.2M
ELV icon
25
Elevance Health
ELV
$84B
$10.9M 1.51%
25,000
-5,000
-17% -$2.27M
1
2 3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Integral Health Asset Management held 97 positions worth $722M, down 11% from $808M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management withdrew a net $23.1M in Q3 2023, closing 32 positions and reducing 14 holdings. Its most notable exit was Centene, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 94% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Integral Health Asset Management opened a new position in DexCom worth $16.3M.

  • Integral Health Asset Management's largest Q3 2023 buy was DexCom: 175,000 shares worth $16.3M.
  • Integral Health Asset Management added most to Tenet Healthcare in Q3 2023, an estimated $23M increase.
  • Integral Health Asset Management's biggest Q3 2023 reduction was Cigna, cutting an estimated $34.2M.
  • Integral Health Asset Management fully exited Centene in Q3 2023, selling an estimated $13.5M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $722M portfolio in Q3 2023.
  • Integral Health Asset Management opened 24 new positions and closed 32 in Q3 2023.
  • Integral Health Asset Management's portfolio value fell 11% quarter-over-quarter to $722M.

Based on Integral Health Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.